drugset / Trial / NCT00063193

National Institute of Neurological Disorders and Stroke (NINDS) Parkinson's Disease Neuroprotection Trial

NCT00063193

RandomizedDouble-blindTreatment

Summary

The goal of this study is to assess the impact of minocycline and creatine on the progression of Parkinson's disease, in order to determine whether it is reasonable to proceed with further study of either of these agents.

Timeline

Start
2003-05
Primary completion
2005-05
Completion
2005-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Creatine Other / unclassified
Subject Minocycline Small molecule

Indications